Nicholas Eugene Perkins, DO - Medicare Internal Medicine in Greenville, SC

Nicholas Eugene Perkins, DO is a medicare enrolled "Hospitalist" physician in Greenville, South Carolina. He went to Lincoln Memorial University Medical Department and graduated in 2007 and has 17 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Prisma Health University Medical Group and his current practice location is 701 Grove Rd, Greenville, South Carolina. You can reach out to his office (for appointments etc.) via phone at (864) 455-4411.

Nicholas Eugene Perkins is licensed to practice in South Carolina (license number 1487) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063706547.

Contact Information

Nicholas Eugene Perkins, DO
701 Grove Rd,
Greenville, SC 29605-4210
(864) 455-4411
(864) 455-4480



Physician's Profile

Full NameNicholas Eugene Perkins
GenderMale
SpecialityInternal Medicine
Experience17 Years
Location701 Grove Rd, Greenville, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Nicholas Eugene Perkins attended and graduated from Lincoln Memorial University Medical Department in 2007
  NPI Data:
  • NPI Number: 1063706547
  • Provider Enumeration Date: 06/02/2011
  • Last Update Date: 05/03/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 3173788700
  • Enrollment ID: I20150220000274

Medical Identifiers

Medical identifiers for Nicholas Eugene Perkins such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063706547NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 1487 (South Carolina)Primary
207R00000XInternal Medicine 1487 (South Carolina)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Prisma Health Greenville Memorial HospitalGreenville, SCHospital
Prisma Health Patewood HospitalGreenville, SCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Prisma Health University Medical Group83259509832201

News Archive

Taro Pharmaceutical Industries' non-sedating barbiturate compound study granted FDA IND exemption

Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.

Researchers explore how parenting is shaped by increasing population diversity

Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.

Viewpoints: Romney's shifts back to moderate?; His misleading comments on pre-existing conditions; Debate's half-truths

Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nicholas Eugene Perkins allows following entities to bill medicare on his behalf.
Entity NamePrisma Health University Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295763217
PECOS PAC ID: 8325950983
Enrollment ID: O20031103000238

News Archive

Taro Pharmaceutical Industries' non-sedating barbiturate compound study granted FDA IND exemption

Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.

Researchers explore how parenting is shaped by increasing population diversity

Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.

Viewpoints: Romney's shifts back to moderate?; His misleading comments on pre-existing conditions; Debate's half-truths

Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

Read more Medical News

› Verified 6 days ago

Entity NameGreenville Health System
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1568532513
PECOS PAC ID: 8123938131
Enrollment ID: O20031212000723

News Archive

Taro Pharmaceutical Industries' non-sedating barbiturate compound study granted FDA IND exemption

Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.

Researchers explore how parenting is shaped by increasing population diversity

Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.

Viewpoints: Romney's shifts back to moderate?; His misleading comments on pre-existing conditions; Debate's half-truths

Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicholas Eugene Perkins is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Nicholas Eugene Perkins, DO
300 E Mcbee Ave Fl 4,
Greenville, SC 29601-2842

Ph: (864) 522-8603
Nicholas Eugene Perkins, DO
701 Grove Rd,
Greenville, SC 29605-4210

Ph: (864) 455-4411

News Archive

Taro Pharmaceutical Industries' non-sedating barbiturate compound study granted FDA IND exemption

Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.

Researchers explore how parenting is shaped by increasing population diversity

Multicultural dynamics. Economic disparities. LGTBQ subtleties. Single-parent prevalence. Diversification of the American family is happening at an unprecedented rate, and while awareness of this increased diversity rises, research for what impact it has on parenting adolescents has been limited.

Viewpoints: Romney's shifts back to moderate?; His misleading comments on pre-existing conditions; Debate's half-truths

Far from being a pitchfork-wielding populist who wants to raze Washington, Romney said he would work with the people he finds there. ... He bragged that in his old job as governor, he met with Democrats every week. He boasted about his bipartisan health care bill. ... he gave us a hint of a strong center-right pragmatic approach.

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon's four marketed specialty pharmaceutical products through 2014.

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

Read more News

› Verified 6 days ago


Hospitalist Doctors in Greenville, SC

Hanaa Benchekroun Belabbes, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605
Phone: 864-455-4411    Fax: 864-455-4480
Artur Adam Charowski, MD
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 20 Medical Ridge Dr, Greenville, SC 29605
Phone: 864-220-7270    Fax: 864-220-7290
Robert Brunson Cartledge Jr., M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 255 Enterprise Blvd Ste 101, Greenville, SC 29615
Phone: 864-454-8120    Fax: 644-548-1258
Dr. Jennifer Erin Harris, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 701 Grove Rd, Greenville, SC 29605
Phone: 864-455-7000    Fax: 864-455-4480
Thomas Clifford Turner,
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605
Phone: 864-455-4411    Fax: 864-455-4480
Dr. Laila Alexandria Hussein, MD
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 701 Grove Rd Fl 5, Greenville, SC 29605
Phone: 864-455-4411    Fax: 864-455-4480

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.